Roche CFO: We Are Fully Committed To Genentech Transaction
January 12 2009 - 2:22PM
Dow Jones News
Roche AG (RHHBY) remains fully committed to its mooted
acquisition of the 44% of Genentech Inc. (DNA) that it doesn't
already own, the company's chief financial officer, Erich Hunziker,
said Monday.
Speaking at the J.P. Morgan Healthcare conference in San
Francisco, Hunziker said Roche wouldn't damage the research and
development departments at the California-based company if the
transaction was successful.
- By Jessica Hodgson, Dow Jones Newswires; 415-439-6455;
jessica.hodgson@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front
page of today's most important business and market news, analysis
and commentary. You can use this link on the day this article is
published and the following day.